Article
Chicago - Outpatient, self-administered chemobiotherapy can be delivered safely and effectively for patients with metastatic melanoma, according to a study presented at the 39th annual meeting of the American Association of Clinical Oncology.
Like what you’re reading? Subscribe to Dermatology Times for weekly updates on therapies, innovations, and real-world practice tips.